Bio-Techne Launches the Enhanced Leo™ System Delivering Advanced Multiplexing and High-Throughput Protein Analysis

Core Insights - Bio-Techne Corporation has launched its next-generation Leo System, which utilizes Simple Western Technology to enhance life science research capabilities [1][4] Product Features - The new Leo System incorporates dual-channel fluorescence detection alongside chemiluminescence, increasing data throughput and efficiency while providing deeper insights from samples [2] - It offers a fourth multiplexing option, allowing researchers to quantify targets with varying expression levels and assess different proteoforms in the same capillary, processing up to 100 capillaries in three hours [2][6] Performance and Precision - The Leo System is noted for its high-throughput capabilities, achieving a variability of only 5-6%, which is considered remarkable in clinical research [3] - The system is designed to deliver unmatched precision and efficiency in protein analysis, enabling faster and more reliable results [4] Market Position - Bio-Techne aims to strengthen its leadership in proteomic analytical instruments with the Leo System, which supports complex assay configurations and compliance with regulatory standards [6] Company Overview - Bio-Techne generated over $1.2 billion in net sales in fiscal 2025 and employs approximately 3,100 people globally, providing innovative tools and reagents for research and clinical diagnostics [5]